In 2011, TLL published 59 papers in peer-reviewed journals and made fi ve
discoveries including the specifi c Enterovirus 711
monoclonal antibodies
which can be further developed as potential therapeutics.
TLL continues to nurture scientifi c talent from around the world and provides
opportunities for them to become leaders in their fi elds.